Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity
Open Access
- 15 September 2015
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 79 (1) , 70-75
Abstract
The role of vascular endothelial growth factor (VEGF) in the pathogenesis of retinopathy of prematurity (ROP) has been clearly established. However, little is known about temporal changes in circulating VEGF concentrations in the preterm infant. The objective was to determine the longitudinal serum concentrations of VEGF in relation to ROP. This study included 52 infants born at n = 33, nonproliferative ROP n = 10, treated for ROP n = 9). VEGF concentrations were analyzed in blood samples collected at birth, at 3 d postnatal age, and then weekly until at least a gestational age of 35 wk. VEGF concentrations at birth did not differ between groups, independent of later ROP status. In contrast, VEGF serum concentrations were significantly higher at first detection of ROP in infants who were later treated for ROP compared to infants without ROP. At the time of laser therapy, serum VEGF concentrations did not differ between groups. Circulatory concentrations of VEGF, in infants who later developed severe ROP, were elevated at the time when ROP first was detected but not at the time when current treatment most often occurred. This supports the need for further studies of circulating VEGF in relation to the timing of ROP treatment.Keywords
This publication has 26 references indexed in Scilit:
- Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of PrematurityAmerican Journal of Ophthalmology, 2012
- Influence of Insulin-Like Growth Factor I and Nutrition During Phases of Postnatal Growth in Very Preterm InfantsPediatric Research, 2011
- Increased Angiogenic Factors Associated With Peripheral Avascular Retina and Intravitreous NeovascularizationArchives of Ophthalmology (1950), 2010
- Simultaneous Analyses of Vitreous Levels of 27 Cytokines in Eyes with Retinopathy of PrematurityOphthalmology, 2009
- Vitreous Levels of Stromal Cell–Derived Factor 1 and Vascular Endothelial Growth Factor in Patients with Retinopathy of PrematurityOphthalmology, 2008
- VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurityBritish Journal of Ophthalmology, 2008
- The Incidence and Course of Retinopathy of Prematurity: Findings From the Early Treatment for Retinopathy of Prematurity StudyPediatrics, 2005
- Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathyExperimental Eye Research, 2004
- Umbilical cord serum vascular endothelial growth factor (VEGF) levels in normal pregnancies and in pregnancies complicated by preterm delivery or pre‐eclampsiaInternational Journal of Gynecology & Obstetrics, 2004
- Changes in serum levels of vascular endothelial growth factor in males and females throughout lifeJournal of the Society for Gynecologic Investigation, 2000